Cargando…
Targeted depletion of PIK3R2 induces regression of lung squamous cell carcinoma
Oncogenic mutations in the PI3K/AKT pathway are present in nearly half of human tumors. Nonetheless, inhibitory compounds of the pathway often induce pathway rebound and tumor resistance. We find that lung squamous cell carcinoma (SQCC), which accounts for ~20% of lung cancer, exhibits increased exp...
Autores principales: | Vallejo-Díaz, Jesús, Olazabal-Morán, Manuel, Cariaga-Martínez, Ariel E., Pajares, María J., Flores, Juana M., Pio, Ruben, Montuenga, Luis M., Carrera, Ana Clara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356720/ https://www.ncbi.nlm.nih.gov/pubmed/27835880 http://dx.doi.org/10.18632/oncotarget.13195 |
Ejemplares similares
-
TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients
por: Pajares, M J, et al.
Publicado: (2014) -
E-cadherin downregulation sensitizes PTEN-mutant tumors to PI3Kβ silencing
por: Millán-Uclés, África, et al.
Publicado: (2016) -
Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology
por: Larzabal, L, et al.
Publicado: (2011) -
Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype
por: Larrayoz, Marta, et al.
Publicado: (2014) -
Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients
por: Villalba, Maria, et al.
Publicado: (2016)